icon-folder.gif   Conference Reports for NATAP  
 
  Back grey_arrow_rt.gif
 
 
 
NYS Durb Final Report - Sept 15 2016 Meeting
 
 
  Download the PDF here
 
Please note that the below changes go into effect on November 17, 2016 and only apply to FFS Medicaid.
 
Attached is the final summary report from the September meeting of the NYS Drug Utilization Review Board. The hepatitis C summary can be found on page 4.
⋅ Epclusa(GT 2 and 3) has been added to the preferred list
⋅ Viekira XR has been added to the preferred list
 
The summary report is also available at:
https://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2016/09/summary_durb.pdf
 
Colleen Flanigan, RN, MS
Director, Bureau of Hepatitis Health Care
New York State Department of Health
AIDS Institute
Empire State Plaza, Corning Tower - 429
Albany, NY 12237
(o) 518-486-6806
(f) 518-474-2749
Email: colleen.flanigan@health.ny.gov
 

NYS